Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43

Polymenidou, Magdalini, Lagier-Tourenne, Clotilde, Hutt, Kasey R, Huelga, Stephanie C, Moran, Jacqueline, Liang, Tiffany Y, Ling, Shuo-Chien, Sun, Eveline, Wancewicz, Edward, Mazur, Curt, Kordasiewicz, Holly, Sedaghat, Yalda, Donohue, John Paul, Shiue, Lily, Bennett, C Frank, Yeo, Gene W, Cleveland, Don W·2011·Nature Neuroscience
DOI 10.1038/nn.2779

Cited by (1,000)

Items 601–700 of 1,000

  1. The Role of Ubiquitin in Regulating Stress Granule Dynamics
    Laura J. Krause, María Georgina Herrera, Konstanze F. Winklhofer · 2022 · Frontiers in Physiology
  2. Prematurely terminated intron-retaining mRNAs invade axons in SFPQ null-driven neurodegeneration and are a hallmark of ALS
    Richard Taylor, Fursham Hamid, Triona Fielding, Patricia M. Gordon, Megan Maloney, Eugene V. Makeyev, Corinne Houart · 2022 · Nature Communications
  3. Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice
    Toshihide Takeuchi, Kazuhiro Maeta, Xin Ding, Yukako Oe, Akiko Takeda, Mana Inoue, Seiichi Nagano, Tsuyoshi Fujihara, Seiji Matsuda, Shinsuke Ishigaki et al. · 2023 · Molecular Therapy — Nucleic Acids
  4. Mitophagy regulation in aging and neurodegenerative disease
    Trupti A. Banarase, Shivkumar S. Sammeta, Nitu L. Wankhede, Shubhada V Mangrulkar, Sandip R. Rahangdale, Manish Manohar Aglawe, Brijesh Gulabrao Taksande, Aman Babanrao Upaganlawar, Milind Janrao Umekar, Mayur Bhimrao Kale · 2023 · Biophysical Reviews
  5. Nuclear face of Tau: an inside player in neurodegeneration
    Neelam Younas, Tayyaba Saleem, Abrar Younas, Inga Zerr · 2023 · Acta Neuropathologica Communications
  6. Homozygous ALS-linked mutations in TARDBP/TDP-43 lead to hypoactivity and synaptic abnormalities in human iPSC-derived motor neurons
    Sarah Lépine, Angela Nauleau-Javaudin, Éric Deneault, Carol X.‐Q. Chen, Narges Abdian, Anna Kristina Franco-Flores, Ghazal Haghi, María José Castellanos‐Montiel, Gilles Maussion, Mathilde Chaineau et al. · 2024 · iScience
  7. Disruption of nuclear speckle integrity dysregulates RNA splicing in C9ORF72-FTD/ALS
    Rong Wu, Yingzhi Ye, Daoyuan Dong, Zhe Zhang, Shaopeng Wang, Yini Li, Noelle Wright, Javier Redding‐Ochoa, Koping Chang, Shaohai Xu et al. · 2024 · Neuron
  8. TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls
    Emanuele Buratti, Maurizio Romano, Francisco Ernesto Baralle · 2013 · Molecular and Cellular Neuroscience
  9. CLIPing the brain: Studies of protein–RNA interactions important for neurodegenerative disorders
    Miha Modic, Jernej Ule, Christopher R. Sibley · 2013 · Molecular and Cellular Neuroscience
  10. Targeting RNA Binding Proteins Involved in Neurodegeneration
    Maurizio Romano, Emanuele Buratti · 2013 · SLAS DISCOVERY
  11. Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related proteins
    Chiara Foglieni, Stéphanie Papin, Agnese Salvadè, Tariq Afroz, Sandra Pinton, Giona Pedrioli, Giorgio Ulrich, Magdalini Polymenidou, Paolo Paganetti · 2017 · Scientific Reports
  12. Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
    Chantal M. Ferguson, Dimas Echeverria, Matthew R. Hassler, Socheata Ly, Anastasia Khvorova · 2020 · Molecular Therapy — Nucleic Acids
  13. The Cellular Prion Protein Increases the Uptake and Toxicity of TDP-43 Fibrils
    Carlo Scialò, Luigi Celauro, Marco Zattoni, Thanh Hoa Tran, Edoardo Bistaffa, Fabio Moda, Robert Kammerer, Emanuele Buratti, Giuseppe Legname · 2021 · Viruses
  14. The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer
    Xueyou Ma, Yufan Ying, Haiyun Xie, Xiaoyan Liu, Xiao Wang, Jiangfeng Li · 2021 · Frontiers in Oncology
  15. FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade
    Pierre De Rossi, Amanda J. Lewis, Johanna Furrer, Laura De Vos, Tomáš Demeter, Aurélie Zbinden, Weijia Zhong, Vera I. Wiersma, Carlo Scialò, Julien Weber et al. · 2021 · EMBO Reports
  16. Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives
    Si Ha, Jiacheng Zhu, Hua Xiang, Guoshun Luo · 2023 · Chinese Chemical Letters
  17. Structural details of helix-mediated multimerization of the conserved region of TDP-43 C-terminal domain
    Azamat Rizuan, Jayakrishna Shenoy, Priyesh Mohanty, Patricia M. dos Passos, José F. Mercado Ortiz, Leanna Bai, Renjith Viswanathan, Julia Zaborowksy, Szu‐Huan Wang, Victoria Johnson et al. · 2025 · Nature Communications
  18. RNA splicing analysis in genomic medicine
    Htoo A. Wai, Andrew G. L. Douglas, Diana Baralle · 2018 · The International Journal of Biochemistry & Cell Biology
  19. RNA-binding protein altered expression and mislocalization in MS
    Katsuhisa Masaki, Yoshifumi Sonobe, Ghanashyam D. Ghadge, Peter Pytel, Paula Lépine, Florian Pernin, Qiao‐Ling Cui, Jack Perry Antel, Stéphanie Zandee, Alexandre Prat et al. · 2020 · Neurology Neuroimmunology & Neuroinflammation
  20. RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
    Pietro Laneve, Paolo Tollis, Elisa Caffarelli · 2021 · International Journal of Molecular Sciences
  21. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia
    Laura Pasetto, Maurizio Grassano, Silvia Pozzi, Silvia Luotti, Eliana Sammali, Alice Migazzi, Manuela Basso, Giovanni Spagnolli, Emiliano Biasini, Edoardo Micotti et al. · 2021 · Brain
  22. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis
    Orietta Pansarasa, Maria Garofalo, Eveljn Scarian, Francesca Dragoni, Jessica Garau, Rosalinda Di Gerlando, Luca Diamanti, Matteo Bordoni, Stella Gagliardi · 2022 · International Journal of Molecular Sciences
  23. Identification of linc-NeD125, a novel long non coding RNA that hosts miR-125b-1 and negatively controls proliferation of human neuroblastoma cells
    Valeria Bevilacqua, Ubaldo Gioia, Valerio Di Carlo, Anna Francesca Tortorelli, Teresa Colombo, Irene Bozzoni, Pietro Laneve, Elisa Caffarelli · 2015 · RNA Biology
  24. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
    Scott E. Ugras, James Shorter · 2012 · Neurology Research International
  25. Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis
    Leanne Jiang, Shyuan Thieu Ngo · 2022 · Metabolites
  26. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis
    Smriti Sangwan, David S Eisenberg · 2016 · Postępy Biochemii
  27. RNA Editing and Retrotransposons in Neurology
    Heinz E. Krestel, Jochen C. Meier · 2018 · Frontiers in Molecular Neuroscience
  28. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration
    Paulo A. Ferreira · 2019 · Cellular and Molecular Life Sciences
  29. Dysfunctional RNA‐binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice
    Hannah E. Salapa, Cole D. Libner, Michael C. Levin · 2019 · Journal of Neuroscience Research
  30. TDP‐43 toxicity is mediated by the unfolded protein response‐unrelated induction of C/EBP homologous protein expression
    Hiroaki Suzuki, Masaaki Matsuoka · 2011 · Journal of Neuroscience Research
  31. TDP-43 upregulation mediated by the NLRP3 inflammasome induces cognitive impairment in 2 2′,4,4′-tetrabromodiphenyl ether (BDE-47)-treated mice
    Juan Zhuang, Xin Wen, Yan-qiu Zhang, Qun Shan, Zi-Feng Zhang, Gui‐Hong Zheng, Shao‐Hua Fan, Mengqiu Li, Dongmei Wu, Bin Hu et al. · 2017 · Brain Behavior and Immunity
  32. TDP-43 proteinopathy in Theiler’s murine encephalomyelitis virus infection
    Katsuhisa Masaki, Yoshifumi Sonobe, Ghanashyam D. Ghadge, Peter Pytel, Raymond P. Roos · 2019 · PLoS Pathogens
  33. TDP-43—The key to understanding amyotrophic lateral sclerosis
    Zuoshang Xu, Chunxing Yang · 2014 · Rare Diseases
  34. Evidence of nuclei-encoded spliceosome mediating splicing of mitochondrial RNA
    Roberto H. Herai, Priscilla Davidson Negraes, Alysson Renato Muotri · 2017 · Human Molecular Genetics
  35. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
    Leslie Bargsted, Danilo B. Medinas, Francisca Martínez Traub, Pablo Rozas, Natalia Muñoz, Melissa Nassif, Carolina Jerez, Alejandra Catenaccio, Felipe A. Court, Claudio A. Hetz et al. · 2017 · Scientific Reports
  36. The Interplay of RNA Binding Proteins, Oxidative Stress and Mitochondrial Dysfunction in ALS
    Jasmine Harley, Benjamin E. Clarke, Rickie Patani · 2021 · Antioxidants
  37. Suppression of premature transcription termination leads to reduced mRNA isoform diversity and neurodegeneration
    Geneva R. LaForce, Jordan S. Farr, Jingyi Liu, Cydni Akesson, Evren Gümüş, Otis W. Pinkard, Helen C. Miranda, Katherine Johnson, Thomas J. Sweet, Ping Ji et al. · 2022 · Neuron
  38. Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein Clearance
    Angela Marie Jablonski, Todd Lamitina, Nicole F. Liachko, Mariangela Sabatella, Jiayin Lu, Lei Zhang, Lyle W. Ostrow, Preetika Gupta, Chia-Yen Wu, Shachee Doshi et al. · 2015 · Journal of Neuroscience
  39. UG Repeats/TDP-43 Interactions near 5′ Splice Sites Exert Unpredictable Effects on Splicing Modulation
    Monica Passoni, Laura De Conti, Marco Baralle, Emanuele Buratti · 2011 · Journal of Molecular Biology
  40. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD
    Marc Shenouda, Ashley B. Zhang, Anna Weichert, Janice Robertson · 2018 · Advances in neurobiology
  41. Biological Spectrum of Amyotrophic Lateral Sclerosis Prions
    Magdalini Polymenidou, Don W. Cleveland · 2017 · Cold Spring Harbor Perspectives in Medicine
  42. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
    Henrick Riemenschneider, Francesca Simonetti, Udit Sheth, Eszter Katona, Stefan Roth, Saskia Hutten, Daniel Farny, Meike Michaelsen, Brigitte Nuscher, Michael K. Schmidt et al. · 2023 · Acta Neuropathologica Communications
  43. RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo
    Natalie M. Scherer, Cindy Maurel, Matthew S. Graus, Luke McAlary, Grant Richter, Rowan A. W. Radford, Alison L. Hogan, Emily K. Don, Albert Lee, Justin J. Yerbury et al. · 2024 · Nucleic Acids Research
  44. Copper toxicity and deficiency: the vicious cycle at the core of protein aggregation in ALS
    Jin-Hong Min, Heela Sarlus, Robert Adam Harris · 2024 · Frontiers in Molecular Neuroscience
  45. Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis
    Philip Van Damme, Wim Robberecht · 2013 · Current Opinion in Neurology
  46. Amyotrophic Lateral Sclerosis Genetic Studies
    Ji He, Marie Mangelsdorf, Dongsheng Fan, Perry Francis Bartlett, Matthew Arthur Brown · 2014 · The Neuroscientist
  47. Links between Electrophysiological and Molecular Pathology of Amyotrophic Lateral Sclerosis
    Katharina A. Quinlan · 2011 · Integrative and Comparative Biology
  48. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD
    Takenari Yamashita, Sayaka Teramoto, Shin Kwak · 2015 · Neuroscience Research
  49. Rapid Evolution of Gained Essential Developmental Functions of a Young Gene via Interactions with Other Essential Genes
    Yuh Chwen G. Lee, Iuri Matteuzzo Ventura, Gavin R. Rice, Dong-Yuan Chen, Serafin U. Colmenares, Manyuan Long · 2019 · Molecular Biology and Evolution
  50. TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish
    Maria‐Letizia Campanari, Anca Marian, Sorana Ciura, Edor Kabashi · 2021 · Cells
  51. TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia
    Frederick J. Arnold, Ya Cui, Sebastian Michels, Michael R. Colwin, Cameron M. Stockford, Wenbin Ye, Vidhya Bharathi, Karen R. Jansen‐West, Julien Philippe, Ravinder Gulia et al. · 2025 · Journal of Clinical Investigation
  52. A Model-Based Approach to Identify Binding Sites in CLIP-Seq Data
    Tao Wang, Beibei Chen, Minsoo Kim, Yang Xie, Guanghua Xiao · 2014 · PLoS ONE
  53. Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease
    Heather R. Minkel, Tooba Z. Anwer, Kara M. Arps, Michael Brenner, Michelle Lynne Olsen · 2015 · Glia
  54. Parallel computation of genome-scale RNA secondary structure to detect structural constraints on human genome
    Risa Karakida Kawaguchi, Hisanori Kiryu · 2016 · BMC Bioinformatics
  55. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice
    Nirma D. Perera, Rebecca K. Sheean, Peter John Crouch, Anthony Robert White, Malcolm Kenneth Horne, Bradley J. Turner · 2016 · Human Molecular Genetics
  56. Cytoplasmic TDP-43 impairs the activity of the ubiquitin-proteasome system
    Peng Yin, Dazhang Bai, Longhong Zhu, Fuyu Deng, Xiangyu Guo, Bang Li, Laiqiang Chen, Shihua Li, Xiaojiang Li · 2021 · Experimental Neurology
  57. Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex
    Yuka Mitsuhashi Koike, Akihiro Sugai, Norikazu Hara, Junko Itô, Akio Yokoseki, Tomohiko Ishihara, Takuma Yamagishi, Shintaro Tsuboguchi, Mari Tada, Takeshi Ikeuchi et al. · 2021 · Communications Biology
  58. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis
    Bridget C. Benson, Pamela J. Shaw, Mimoun Azzouz, J. Robin Highley, Guillaume M. Hautbergue · 2021 · Frontiers in Neuroscience
  59. RBM20S639G mutation is a high genetic risk factor for premature death through RNA-protein condensates
    Chunyan Wang, Yanghai Zhang, Mei Methawasin, Camila Urbano Braz, Jeffrey Gao-Hu, Betty Yang, Joshua G. Strom, Jochen Gohlke, Timothy A. Hacker, Hasan Khatib et al. · 2022 · Journal of Molecular and Cellular Cardiology
  60. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD
    Kent Imaizumi, Hirosato Ideno, Tsukika Sato, Satoru Morimoto, Hideyuki Okano · 2022 · eNeuro
  61. Amyotrophic lateral sclerosis
    David S. Younger, Robert H. Brown · 2023 · Handbook of clinical neurology
  62. Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant
    Heike J. Wobst, Louise Delsing, Nicholas J. Brandon, Stephen J. Moss · 2017 · PLoS ONE
  63. Variation in single-nucleotide sensitivity of eCLIP derived from reverse transcription conditions
    Eric L. Van Nostrand, Alexander A. Shishkin, Gabriel A. Pratt, Thai B. Nguyen, Gene Wei-Ming Yeo · 2017 · Methods
  64. SMN complex member Gemin3 self-interacts and has a functional relationship with ALS-linked proteins TDP-43, FUS and Sod1
    Rebecca Cacciottolo, Joanna Ciantar, Maia Lanfranco, Rebecca M. Borg, Neville Vassallo, Rémy Bordonné, Ruben J. Cauchi · 2019 · Scientific Reports
  65. To Be or Not To Be…Toxic—Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration?
    Suvithanandhini Loganathan, Erik M. Lehmkuhl, Randall J. Eck, Daniela C. Zarnescu · 2020 · Frontiers in Molecular Biosciences
  66. Elevated nuclear TDP-43 induces constitutive exon skipping
    Carmen-Orozco, Rogger P., Tsao, William, Ye, Yingzhi, Sinha, Irika R., Chang, Koping, Trinh, Vickie T., Chung, William, Bowden, Kyra, Troncoso, Juan C., Blackshaw, Seth et al. · 2024 · Molecular Neurodegeneration
  67. Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
    Kiterie M. E. Faller, Helena Chaytow, Thomas Henry Gillingwater · 2025 · Nature Reviews Neurology
  68. RNA quality control and protein aggregates in amyotrophic lateral sclerosis: A review
    Ashok K. Verma, Rup Tandan · 2012 · Muscle & Nerve
  69. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function
    Anna G. Drannik, Joan Martin, Randy Peterson, Xiaoxing Ma, Fan Jiang, John Turnbull · 2017 · PLoS ONE
  70. Expression and correlation of MALAT1 and SOX9 in non‐small cell lung cancer
    Wei Chen, Wei Zhao, Sheng Chen, Li Zhang, Zhongying Guo, Lixin Wang, Jipeng Wang, Zongren Wan, Yongqing Hong, Liang Yu · 2018 · The Clinical Respiratory Journal
  71. RNA-Binding Proteins and the Complex Pathophysiology of ALS
    Wanil Kim, Do‐Yeon Kim, Kyung‐Ha Lee · 2021 · International Journal of Molecular Sciences
  72. Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation
    Jae‐Hong Kim, Md. Habibur Rahman, Donghwi Park, Myungjin Jo, Hyung-Jun Kim, Kyoungho Suk · 2021 · Cells
  73. NEAT1 lncRNA and amyotrophic lateral sclerosis
    Yoshinori Nishimoto, Shinichi Nakagawa, Hideyuki Okano · 2021 · Neurochemistry International
  74. Pu-Erh Tea Extract Induces the Degradation of FET Family Proteins Involved in the Pathogenesis of Amyotrophic Lateral Sclerosis
    Yang Yu, Shuhei Hayashi, Xianbin Cai, Chongye Fang, Wei Shi, Hiroko Tsutsui, Jun Sheng · 2014 · BioMed Research International
  75. A network of RNA and protein interactions in Fronto Temporal Dementia
    Francesca Fontana, Kavitha Siva, Michela A. Denti · 2015 · Frontiers in Molecular Neuroscience
  76. PABPN1 suppresses TDP-43 toxicity in ALS disease models
    Ching‐Chieh Chou, Alexeeva Olga, Shizuka B. Yamada, Amy K. Pribadi, Yi Zhang, Mo Bi, Kathryn R. Williams, Daniela C. Zarnescu, Wilfried Rossoll · 2015 · Human Molecular Genetics
  77. Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro
    Heike J. Wobst, Steven S. Wesolowski, Jayashree Chadchankar, Louise Delsing, Steven Jacobsen, Jayanta T. Mukherjee, Tarek Z. Deeb, John Dunlop, Nicholas J. Brandon, Stephen J. Moss · 2017 · Frontiers in Molecular Neuroscience
  78. Identification of Qk as a Glial Precursor Cell Marker that Governs the Fate Specification of Neural Stem Cells to a Glial Cell Lineage
    Akihide Takeuchi, Yuji Takahashi, Kei Iida, Motoyasu Hosokawa, Koichiro Irie, Mikako Ito, J.B. Brown, Kinji Ohno, Kinichi Nakashima, Masatoshi Hagiwara · 2020 · Stem Cell Reports
  79. Yeast genetic screen reveals novel therapeutic strategy for ALS
    Matthew D. Figley, Aaron D. Gitler · 2013 · Rare Diseases
  80. TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD
    Brian J. Joseph, Kelly A. Marshall, Peter Harley, Jacob R. Mann, Francesco Alessandrini, Carlos G. Vanoye, Wanhao Chi, Mercedes Prudencio, Dina Simkin, Tzu-Ting Kao et al. · 2025 · Nature Neuroscience
  81. Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons
    Kyoungin Cho, Dosuk Yoon, Minzhong Yu, Neal S. Peachey, Paulo A. Ferreira · 2019 · Cellular and Molecular Life Sciences
  82. Identification of molecular signatures and pathways common to blood cells and brain tissue of amyotrophic lateral sclerosis patients
    Md Rezanur Rahman, Tania Islam, Fazlul Huq, Julian M.W. Quinn, Mohammad Ali Moni · 2019 · Informatics in Medicine Unlocked
  83. Studying ALS: Current Approaches, Effect on Potential Treatment Strategy
    Elizaveta Ustyantseva, Sergey P. Medvedev, Suren M. Zakian · 2020 · Advances in experimental medicine and biology
  84. Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries
    Claudia A. Duran-Aniotz, Paulina Orellana, Tomás León Rodríguez, Fernando Henríquez, Victoria Cabello, María F. Aguirre-Pinto, Tamara Escobedo, Leonel Tadao Takada, Stefanie Danielle Piña‐Escudero, Oscar L. López et al. · 2021 · Frontiers in Neurology
  85. A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS
    Marc Shenouda, Shangxi Xiao, Laura MacNair, Agnes Lau, Janice Robertson · 2022 · Frontiers in Neuroscience
  86. Neural circuit and synaptic dysfunctions in ALS-FTD pathology
    Santiago Mora, Ilary Allodi · 2023 · Frontiers in Neural Circuits
  87. Characterization of FUS Mutations in Amyotrophic Lateral Sclerosis Using RNA-Seq
    Marka van Blitterswijk, Eric T. Wang, Brad A. Friedman, Pamela J. Keagle, Patrick Lowe, Ashley Lyn LeClerc, Leonard H. van den Berg, David E. Housman, Jan Herman Veldink, John E. Landers · 2013 · PLoS ONE
  88. Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration
    Yair M. Gozal, Nicholas T. Seyfried, Marla Gearing, Jonathan D. Glass, Craig J. Heilman, Joanne Wuu, Duc Minh Duong, Dongmei Cheng, Qiangwei Xia, Howard D. Rees et al. · 2011 · Molecular Neurodegeneration
  89. HITS-CLIP Analysis Uncovers a Link between the Kaposi’s Sarcoma-Associated Herpesvirus ORF57 Protein and Host Pre-mRNA Metabolism
    Emi Sei, Tao Wang, Olga V. Hunter, Yang Xie, Nicholas K. Conrad · 2015 · PLoS Pathogens
  90. TBPH/TDP-43 modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5′UTR
    Maurizio Romano, Fabian M. Feiguin, Emanuele Buratti · 2016 · Brain Research
  91. TDP-43 in the spectrum of MND-FTLD pathologies
    Lanier Heyburn, Charbel Moussa · 2017 · Molecular and Cellular Neuroscience
  92. TDP ‐43 accelerates deadenylation of target mRNA s by recruiting Caf1 deadenylase
    Makoto Fukushima, Nao Hosoda, Kotaro Chifu, Shin-ichi Hoshino · 2018 · FEBS Letters
  93. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies
    Pei‐Chuan Ho, Tsung‐Chi Hsieh, Kuen‐Jer Tsai · 2024 · Ageing Research Reviews
  94. Divergent Phenotypes in Mutant TDP-43 Transgenic Mice Highlight Potential Confounds in TDP-43 Transgenic Modeling
    Simon D’Alton, Marcelle S. Altshuler, Ashley D. Cannon, Dennis W. Dickson, Leonard Petrucelli, Jada M. Lewis · 2014 · PLoS ONE
  95. Therapeutic and diagnostic challenges for frontotemporal dementia
    Simon Dâ€TMAlton, Jada M. Lewis · 2014 · Frontiers in Aging Neuroscience
  96. Nanoscale Analysis Reveals the Maturation of Neurodegeneration-Associated Protein Aggregates: Grown in mRNA Granules then Released by Stress Granule Proteins
    Sanae Abrakhi, Dmitry A. Kretov, Bénédicte Desforges, Ioana L. Dobra, Ahmed Bouhss, David Pastré, Loïc Hamon · 2017 · ACS Nano
  97. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders
    Giovanna Grimaldi, Giuliana Catara, Luca Palazzo, Annunziata Corteggio, Carmen Valente, Daniela Corda · 2019 · Biochemical Pharmacology
  98. Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem Cell-Derived Motor Neurons
    Jasmine Harley, Rickie Patani · 2020 · International Journal of Molecular Sciences
  99. Advances in sequencing technologies for amyotrophic lateral sclerosis research
    Evan Udine, Angita Jain, Marka van Blitterswijk · 2023 · Molecular Neurodegeneration
  100. Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
    Min Qu, Huijun Zhang, Pengyuan Cheng, Ashenafi Kiros Wubshet, Xiangping Yin, Xiangwei Wang, Yuefeng Sun · 2023 · Frontiers in Immunology